Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Activities:
Net loss	$ (40,817)	$ (56,874)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for credit loss	53	8
Depreciation and amortization	3,993	3,789
Amortization-debt issuance costs and investment discount	566	550
Payment-in-kind interest	1,070	1,015
Equity-based compensation and common stock payments	28,047	20,388
Non-cash lease expense	715	648
Changes in operating assets and liabilities:
Accounts receivable	(26,050)	(9,326)
Prepaid expenses and other current assets	(5,079)	(9,547)
Other assets	(167)	(6)
Medical expenses payable	29,077	16,069
Accounts payable and accrued expenses	(1,656)	(298)
Accrued compensation	(364)	(3,691)
Lease liabilities	(1,026)	(832)
Net cash used in operating activities	(11,638)	(38,107)
Investing Activities:
Purchase of business, net of cash received	(1,113)	0
Purchase of investments	(850)	(750)
Sale of investments	750	750
Acquisition of property and equipment	(4,914)	(4,446)
Net cash used in investing activities	(6,127)	(4,446)
Financing Activities:
Equity repurchase	0	(1,474)
Issuance of common stock	0	390,600
Common stock issuance costs	0	(25,467)
Net cash provided by financing activities	0	363,659
Net increase (decrease) in cash	(17,765)	321,106
Cash and restricted cash at beginning of period	468,350	207,811
Cash and restricted cash at end of period	450,585	528,917
Supplemental disclosure of cash flow information:
Cash paid for interest	2,758	2,682
Supplemental non-cash investing and financing activities:
Acquisition of property in accounts payable	331	474
Purchase of business in accounts payable	240	0
Common stock issuance costs included in accounts payable and accrued expenses	0	3,532
Reconciliation of cash, cash equivalents and restricted cash as shown in the statement of cash flows:
Cash	448,835	528,417
Restricted cash in other assets	1,750	500
Total	$ 450,585	$ 528,917